[Opinion] Europe Rapidly Falling Behind China in Pharma, AstraZeneca CEO Warns
2 Articles
2 Articles
Safeguards Of Dapagliflozin's Half Billion USD Sales In China: Astrazeneca. - Conventus Law
Introduction In December 2024, the State Council issued the “Opinions on Comprehensively Deepening the Reform of the Supervision of Drugs and Medical Devices to Promote the High-Quality Development of the Pharmaceutical Industry” ([2024] No. 53). These opinions emphasize the need to accelerate the patent portfolio for innovations in drugs and medical devices, and to enhance both the quality of patents and the efficiency of their transformation …
Coverage Details
Bias Distribution
- 100% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage